查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
棘突间间隔器市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1273371

棘突间间隔器市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Interspinous Spacers Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，棘突间垫片市场预计将以 5.4% 的复合年增长率增长。

COVID-19 大流行最初对棘突间垫片市场产生了负面影响。 由于没有药物或疫苗，传染性病毒感染突然爆发并导致全球封锁。 非 COVID 治疗，如手术和非紧急医疗护理，已被暂时推迟或取消。 该病毒的风险也减少了因非 COVID 问题而去医院就诊的患者数量。 脊柱手术中使用的椎间垫片也受到 COVID-19 限制的不利影响。 2021 年 12 月发表在《骨科创伤杂誌》上的一项研究发现，在 COVID-19 封锁的早期阶段，来自英国急诊科的急性脊柱转诊减少了 20% 以上。 2021 年 7 月发表在《脊柱杂誌》上的一项研究称，他们的研究发现，超过三分之一的择期脊柱手术因 COVID-19 而被取消。

然而，在大流行后随着封锁的解除和非 COVID、非紧急治疗、手术和程序的恢復，棘突间市场有望恢復前的增长速度大流行时期。 2021 年美国骨科医师学会宣布，美国因 COVID-19 而推迟的非紧急骨科手术已在全国范围内恢復。 因此，COVID-19 爆发对之前的市场增长产生了负面影响。 此外，由于选择性脊柱手术和恢復治疗，全球椎间垫片的使用逐渐增加，预计该市场将进一步稳步增长。

此外，椎间垫片在老年人群中的发生率更高。 全球老年人口正在增加，对椎管狭窄微创手术的需求不断增长，促进了这一市场的增长。 根据 2020 年世界卫生组织 (WHO) 的一份报告，到 2030 年，地球上将有六分之一的人超过 60 岁。 预计 60 岁及以上的人口将从 2020 年的 10 亿增长到 2050 年的 14 亿。 到 2050 年，世界 60 岁以上人口将翻一番，达到 21 亿。 2020 年至 2050 年间，80 岁及以上的人口数量预计将增加两倍，达到 4.26 亿。

此外，该领域的技术进步日新月异，椎间垫片的需求量也越来越大。 然而，与椎间垫片相关的彙编正在抑制整个市场的增长，尤其是在老年人群中。 因此，由于上述因素，预计该市场在分析期内将出现增长。 然而，与腰椎融合手术相关的并发症可能会阻碍市场增长。

椎间垫片的市场趋势

腰椎管狭窄段有望主导市场

腰椎管狭窄症是一种椎管变窄并压迫从下背部到腿部的神经的疾病。 由于发育原因，腰椎管狭窄症可能在年轻人中发生，但它通常是一种退行性疾病，发生在60岁及以上的人群中。 腰椎管狭窄症的高患病率及其管理技术的进步正在推动这一领域的增长。 据 JAMA Patient Page 报导，截至 2022 年 5 月，美国将有超过 11% 的老年人患有腰椎管狭窄症。 根据 2022 年 4 月发表在《疼痛研究杂誌》(Journal of Pain Research) 上的一项研究，椎间垫片已被用于通过减轻疼痛、改善活动能力和减少阿片类药物使用来治疗腰椎管狭窄症的临床研究，并且作为一项科学研究得到了高度研究。 本研究建议使用椎间垫片治疗轻度至中度椎管狭窄。

市场参与者获得了用于治疗腰椎管狭窄症的先进产品的批准。 例如，2022 年 7 月，Aurora Spine Corporation 获得了 FDA 批准用于治疗腰椎管狭窄症的 ZIP 系列 MIS 植入物。 ZIP Implant Spacer 是无螺丝和微创的，与传统手术和其他介入手术相比具有优势。

因此，由于上述因素（如高患病率和先进技术），预计腰椎管狭窄领域在预测期内将出现显着增长。

Interspinous Spacers Market-IMG1

北美有望主导棘突间隔器市场

由于人口老龄化程度高和医疗保健支出高等因素，预计北美将主导该市场。 该地区的老龄化人口正在增加，并且容易患椎管狭窄，推动了该地区的市场增长。 根据加拿大统计局的数据，在2022年4月的2021年人口普查中，加拿大85岁及以上的人口估计超过861,000人，占总人口的2.3%以上，2001年的人口基数可以看到多年来翻了一番。 85+年龄段在2021年增长最快，2016-2021年增长率达到16%。 然而，该地区也拥有完善的医疗保健系统，并为此投入了大量资金进行研发。 因此，世界上大部分的治疗方法都可以在该地区获得。 根据研究组合在线报告工具 (RePORT)，2022 年 5 月，2021 年在创伤性头部和脊柱损伤研究/疾病领域的支出超过 1.85 亿美元。 预计这一支出将在 2022 年增至 3.25 亿美元，并在 2023 年进一步增至 3.37 亿美元。 根据加拿大健康信息研究所 (CIHI) 的数据，2022 年 11 月，加拿大在医疗保健方面的支出超过 3.31 亿加元（每个加拿大人 8,563 加元）。 因此，所有这些因素帮助许多全球参与者在该地区开展业务。 因此，市场已经发展壮大，并有望在未来发展。 因此，由于上述因素，预计北美地区的市场将会增长。

Interspinous Spacers Market-IMG2

棘间垫片行业概况

棘突间垫片市场由几家在全球和区域运营的公司适度整合。 竞争格局包括 Life Spine, Inc.、Boston Scientific、Globus Medical, Inc.、ATEC Spine, Inc.、Veritas Health, LLC、Johnson & Johnson、Surgalign Spine Technologies、Aurora Spine, Inc。它还包括对知名公司的分析那占

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 调查假设和市场定义
  • 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 对微创解决方案的需求不断增长
    • 老年人口增加
    • 棘间间隔物的研究与技术进步
  • 市场製约因素
    • 与腰椎融合手术相关的并发症
  • 波特五力
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模）

  • 按类型
    • 静态（不可压缩）垫片
    • 动态（可压缩）垫片
  • 通过使用
    • 腰椎管狭窄症
    • 退行性椎间盘疾病
    • 其他
  • 最终用户
    • 医院
    • 骨科诊所
    • 门诊手术中心
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Life Spine, Inc.
    • Boston Scientific
    • Globus Medical, Inc.
    • ATEC Spine, Inc
    • Stryker
    • Johnson & Johnson
    • Surgalign Spine Technologies, Inc.
    • Aurora Spine, Inc.

第七章市场机会与未来趋势

简介目录
Product Code: 67467

The Interspinous Spacers market is expected to register a CAGR of 5.4% over the forecast period.

The COVID-19 pandemic has had an adverse impact on the Interspinous Spacers market initially. The sudden outbreak of the contagious viral infection and the absence of any medication or vaccine led to a lockdown globally. The non-COVID treatment, such as surgical interventions and non-urgent medical treatment, was temporarily postponed or canceled. Also, the risk of the virus reduced the number of patients visiting the hospital for non-COVID issues. The interspinous spacers are used in spinal surgeries, which was also adversely impacted by the COVID-19 restrictions. According to a study published in the Journal of Orthopaedic Trauma in December 2021, there was a reduction of over 20% in acute spinal referrals from UK emergency departments during the COVID-19 lockdown initial phase. A study published in the Spine Journal in July 2021 stated that over one-third of elective spine, surgeries were canceled, as per their study, due to COVID-19.

However, in the post-pandemic with the lifting of the lockdown and the resumption of the non-COVID, non-urgent treatment, surgeries, and procedures, the interspinous space market is expected to regain its growth pace as it was in the pre-pandemic period. American Academy of Orthopaedic Surgeons in 2021 stated that the non-essential orthopedic surgeries which were postponed in the United States due to COVID-19 had been resumed across the country. Thus, the COVID-19 outbreak has adversely impacted the market's growth in its preliminary phase. Moreover, the market is expected to grow further at a stable pace with the resumption of elective spine surgeries and treatment, which would gradually increase the use of interspinous spacers globally.

Further, the interspinous spacer has a higher occurrence in the geriatric population. As the geriatric population is increasing globally, and there is an increasing demand for minimally invasive procedures for spinal stenosis that has helped in the growth of this market. According to the World Health Organization report (WHO) report in 2020, by 2030, 1 out of every six people on the planet will be 60 years old or older. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will double to reach 2.1 billion. Between 2020 and 2050, the number of people aged 80 and above is expected to triple, reaching 426 million.

In addition, there are also increasing technological advancements seen in this field; therefore, the demand for interspinous spacers is increasing. However, compilations related to the interspinous spacer, especially in the older population, have been restraining the overall growth of the market. Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the complications associated with lumbar spinal fusion are likely to impede the market growth.

Interspinous Spacers Market Trends

Lumbar Spinal Stenosis Segment is Expected to Dominate the Market

Lumbar spinal stenosis is a narrowing of the spinal canal, compressing the nerves traveling through the lower back into the legs. While it may affect younger patients due to developmental causes, it is more often a degenerative condition that affects people who are typically aged 60 and older. The high prevalence and advancing technology of lumbar spinal stenosis and its management are boosting the growth of the segment. According to JAMA Patient Page, in May 2022, over 11% of elderly adults in the United States have the condition of Lumbar spinal stenosis. According to a study published in the Journal of Pain Research in April 2022, interspinous spacers are highly studied for clinical research and scientific studies for the management of lumbar spinal stenosis by reducing pain, improving mobility, and reduction in the use of opiates. The study has recommended the use of interspinous spacers for mild-to-moderate spinal lumbar stenosis.

The players in the market have received approval for their advanced products for the management of lumbar spinal stenosis. For instance, in July 2022, Aurora Spine Corporation received FDA clearance for its ZIP family of MIS implants for the management of lumbar spinal stenosis. The ZIP implant spacer has no screw and is minimally invasive, which bears an edge over traditional surgeries and other interventional procedures.

Therefore, the lumbar spinal stenosis segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including its high prevalence and advancing technology.

Interspinous Spacers Market - IMG1

North America is Expected to Dominate the Interspinous Spacers Market

North America is expected to dominate the market owing to factors such as the vast geriatric population and high healthcare expenditure. The geriatric population in the region is expanding and is susceptible to spinal stenosis; thus, the aging population drives the growth of the market in the region. According to Statistics Canada, in April 2022, over 861,000 people in Canada were estimated to be aged 85 and above in the 2021 Census, representing over 2.3% of the total population, which shows that the age group population base has doubled from 2001. The age group of 85 years and above was the fastest growing in 2021, with a growth rate of 16% from 2016 to 2021. However, the region also has well-developed healthcare systems and also spends huge amounts in research and development for the same. As a result, most of the global treatments are available in this region. According to the Research Portfolio Online Reporting Tools (RePORT), in May 2022, over USD 185 million had been spent on the research/ disease area of traumatic head and spine injury in 2021. This expenditure was estimated to increase to USD 325 million in 2022 and further to USD 337 million in 2023. According to the Canadian Institute for Health Information (CIHI), in November 2022, Canada spent over CAD 331 million on healthcare (CAD 8,563 per Canadian) in 2022. Hence all these factors have helped many global players to make their presence in this region. As a result, the market has grown and is also expected to grow in the future. Therefore, owing to the previously mentioned factors, the growth of the studied market is anticipated in the North America Region.

Interspinous Spacers Market - IMG2

Interspinous Spacers Industry Overview

The interspinous spacers market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international as well as local companies that hold market shares and are well known, including Life Spine, Inc., Boston Scientific, Globus Medical, Inc., ATEC Spine, Inc, Veritas Health, LLC., Johnson & Johnson, Surgalign Spine Technologies, Inc., Aurora Spine, Inc. among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Minimally Invasive Solutions
    • 4.2.2 Increasing Geriatric Population
    • 4.2.3 Growth in Research and Technological Advancements in Interspinous Spacers
  • 4.3 Market Restraints
    • 4.3.1 Complications associated with Lumbar Spinal Fusion
  • 4.4 Porter Five Forces
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Static (Non-compressible Spacers)
    • 5.1.2 Dynamic (Compressible Spacers)
  • 5.2 By Application
    • 5.2.1 Lumbar Spinal Stenosis
    • 5.2.2 Degenerative Disc Diseases
    • 5.2.3 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Orthopedic Clinics
    • 5.3.3 Ambulatory Surgical Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Life Spine, Inc.
    • 6.1.2 Boston Scientific
    • 6.1.3 Globus Medical, Inc.
    • 6.1.4 ATEC Spine, Inc
    • 6.1.5 Stryker
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Surgalign Spine Technologies, Inc.
    • 6.1.8 Aurora Spine, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS